Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial

医学 乙状结肠镜检查 随机化 随机对照试验 肿瘤科 前列腺癌 结直肠癌 前列腺 直肠检查 内科学 妇科 癌症 临床终点 阶段(地层学) 卵巢癌 前列腺癌筛查 前列腺特异性抗原 结肠镜检查 古生物学 生物
作者
Philip C. Prorok,Gerald L. Andriole,Robert S. Bresalier,Saundra S. Buys,David Chia,E. David Crawford,Ronald Fogel,Edward P. Gelmann,Fiona J. Gilbert,Marsha Hasson,Richard B. Hayes,Christine Cole Johnson,Jack S. Mandel,Albert Oberman,Barbara O’Brien,Martin M. Oken,Sameer Rafla,Douglas J. Reding,Wilmer M. Rutt,Joel L. Weissfeld
出处
期刊:Controlled Clinical Trials [Elsevier]
卷期号:21 (6): 273S-309S 被引量:1014
标识
DOI:10.1016/s0197-2456(00)00098-2
摘要

The objectives of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial are to determine in screenees ages 55-74 at entry whether screening with flexible sigmoidoscopy (60-cm sigmoidoscope) can reduce mortality from colorectal cancer, whether screening with chest X-ray can reduce mortality from lung cancer, whether screening men with digital rectal examination (DRE) plus serum prostate-specific antigen (PSA) can reduce mortality from prostate cancer, and whether screening women with CA125 and transvaginal ultrasound (TVU) can reduce mortality from ovarian cancer. Secondary objectives are to assess screening variables other than mortality for each of the interventions including sensitivity, specificity, and positive predictive value; to assess incidence, stage, and survival of cancer cases; and to investigate biologic and/or prognostic characterizations of tumor tissue and biochemical products as intermediate endpoints. The design is a multicenter, two-armed, randomized trial with 37,000 females and 37,000 males in each of the two arms. In the intervention arm, the PSA and CA125 tests are performed at entry, then annually for 5 years. The DRE, TVU, and chest X-ray exams are performed at entry and then annually for 3 years. Sigmoidoscopy is performed at entry and then at the 5-year point. Participants in the control arm follow their usual medical care practices. Participants will be followed for at least 13 years from randomization to ascertain all cancers of the prostate, lung, colorectum, and ovary, as well as deaths from all causes. A pilot phase was undertaken to assess the randomization, screening, and data collection procedures of the trial and to estimate design parameters such as compliance and contamination levels. This paper describes eligibility, consent, and other design features of the trial, randomization and screening procedures, and an outline of the follow-up procedures. Sample-size calculations are reported, and a data analysis plan is presented.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
丘比特应助zyt采纳,获得10
刚刚
肥猫啊平发布了新的文献求助10
刚刚
李健应助科研通管家采纳,获得10
刚刚
风中冰香应助科研通管家采纳,获得10
刚刚
wanci应助佳语妍说采纳,获得10
1秒前
英姑应助科研通管家采纳,获得10
1秒前
浮游应助科研通管家采纳,获得10
1秒前
负责月光发布了新的文献求助10
1秒前
浮游应助科研通管家采纳,获得10
1秒前
星辰大海应助科研通管家采纳,获得10
1秒前
科研通AI6应助科研通管家采纳,获得10
1秒前
1秒前
往好处想完成签到,获得积分10
1秒前
科研通AI6应助科研通管家采纳,获得10
1秒前
2秒前
KevinLeng完成签到,获得积分20
3秒前
LYNB完成签到 ,获得积分10
3秒前
赵梓蓉发布了新的文献求助10
3秒前
CodeCraft应助Amanda采纳,获得10
3秒前
传奇3应助CDI和LIB采纳,获得10
3秒前
YUN完成签到,获得积分10
3秒前
4秒前
小石头完成签到,获得积分10
4秒前
4秒前
4秒前
彭于晏应助test采纳,获得10
5秒前
5秒前
Madge完成签到,获得积分10
6秒前
6秒前
刘笑完成签到 ,获得积分10
6秒前
YY土豆侠完成签到,获得积分10
6秒前
wb完成签到 ,获得积分10
7秒前
石油醚完成签到,获得积分10
7秒前
7秒前
清新的含羞草完成签到,获得积分10
7秒前
7秒前
7秒前
大气听枫发布了新的文献求助10
8秒前
8秒前
anan应助纯真雁菱采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Social Work Ethics Casebook: Cases and Commentary (revised 2nd ed.).. Frederic G. Reamer 1070
Item Response Theory 1000
Introduction to Early Childhood Education 1000
2025-2031年中国兽用抗生素行业发展深度调研与未来趋势报告 1000
List of 1,091 Public Pension Profiles by Region 921
Identifying dimensions of interest to support learning in disengaged students: the MINE project 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5427451
求助须知:如何正确求助?哪些是违规求助? 4541045
关于积分的说明 14175560
捐赠科研通 4458946
什么是DOI,文献DOI怎么找? 2445170
邀请新用户注册赠送积分活动 1436371
关于科研通互助平台的介绍 1413758